InVivo Therapeutics Corporation Reports Third Quarter 2013 Financial Results
Published: Nov 08, 2013
InVivo Therapeutics Holdings Corp. (NVIV), a life sciences company focused on the development and commercialization of novel drug delivery technologies as well as biopolymer devices for the treatment of spinal cord injuries and other nervous system conditions, today reported financial results for the three and nine months ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.